奥斯托尔通过抑制ADRA1D依赖的Th17细胞分化来改善与肥胖相关的脂质代谢障碍
1Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, China.
Scientific reports
|October 21, 2025
概括
奥斯托尔 (OST) 通过向ADRA1D介导的T辅助17细胞分化来对抗与肥胖相关的炎症和代谢问题. 这种天然化合物为免疫代谢障碍提供了潜在的治疗益处.
科学领域:
- 免疫学 免疫学 免疫学
- 代谢疾病 代谢疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 肥胖与代谢失调和慢性炎症有关.
- 辅助性T17 (Th17) 细胞在与代谢障碍相关的炎症反应中起作用.
- 正在探索天然化合物的治疗潜力,以控制与肥胖相关的并发症.
研究的目的:
- 研究Osthol (OST) 对与肥胖相关的代谢失调和炎症的影响.
- 为了确定OST是否通过准ADRA1D介导的Th17细胞分化来改善这些情况.
- 阐明OST作用的潜在分子机制.
主要方法:
- 高脂肪饮食 (HFD) 诱导的肥胖小鼠被OST治疗.
- 代谢参数,与Th17相关的标记物和炎症性细胞因子被评估,使用生物化学测试,流细胞计,ELISA,RT-qPCR和西班牙白斑.
- 采用了Th17分化和脂质代谢的体外模型,通过过度表达调节ADRA1D.
主要成果:
- OST显著降低了HFD诱导的体重增加,肝/脂肪质量,血清脂质,肝酶和脂肪细胞缩.
- OST抑制了Th17分化和促炎性细胞因子的产生,同时增加了抗炎性细胞因子.
- 通过ADRA1D,OST调节了与Th17相关的信号,而ADRA1D过度表达减弱了OST的有益作用.
结论:
- 奥斯托尔通过抑制ADRA1D介导的Th17分化来改善与肥胖相关的代谢失调和炎症.
- ADRA1D被认为是OST治疗效果的关键调解者.
- 在免疫代谢疾病中,OST是潜在的治疗点.
相关概念视频
Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Lipid Absorption
2.4K
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
2.4K
Lipid Digestion
98.6K
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
98.6K


